Diagnostic Radiology, Amakusa Medical Center, Kameba 854-1, Amakusa, Kumamoto 863-0046, Japan.
Jpn J Radiol. 2013 Feb;31(2):115-22. doi: 10.1007/s11604-012-0158-4. Epub 2012 Nov 30.
We compared the fixed injection rate protocol (P2) with the fixed injection duration protocol (P1) for coronary CT angiography using the test bolus technique.
We randomly assigned 100 patients to one of two protocols. In P1, they received 0.7 mL/kg Iohexol-350 in an injection duration of 9 s, and we selected a delay of 3 s after peak enhancement of test bolus scan. In P2, they received 0.7 mL/kg Iohexol-350 at an injection rate of 5 mL/s, and we selected a delay after peak enhancement of test bolus scan using the following formula: TID/2-2 s, where TID is the injection duration of full bolus. We compared attenuation values in the ascending aorta and coronary arteries and patient-to-patient enhancement variability at each segment.
At all segments, CT attenuations of P2 were significantly greater than those of P1 (ascending aorta 400 ± 64 vs. 368 ± 60, P = 0.01; left main trunk 399 ± 67 vs. 369 ± 55, P = 0.02; proximal-RCA 393 ± 66 vs. 363 ± 56, P = 0.01). There was no significant difference in patient-to-patient enhancement variability at all segments between the two groups (P > 0.05).
P2 yielded superior vessel enhancement and comparable patient-to-patient enhancement variability compared with P1 in thin patients.
我们比较了固定注射速率方案(P2)和固定注射持续时间方案(P1)在使用测试团注技术的冠状动脉 CT 血管造影中的应用。
我们将 100 例患者随机分为两组。在 P1 组中,他们以 9 s 的注射持续时间接受 0.7 mL/kg 碘海醇-350,我们选择在测试团注扫描的峰值增强后 3 s 进行延迟。在 P2 组中,他们以 5 mL/s 的注射速率接受 0.7 mL/kg 碘海醇-350,我们使用以下公式选择测试团注扫描的峰值增强后的延迟:TID/2-2 s,其中 TID 为全团注的注射持续时间。我们比较了升主动脉和冠状动脉的衰减值以及每个节段的患者间增强变异性。
在所有节段,P2 的 CT 衰减值均显著大于 P1(升主动脉 400 ± 64 比 368 ± 60,P = 0.01;左主干 399 ± 67 比 369 ± 55,P = 0.02;近端-RCA 393 ± 66 比 363 ± 56,P = 0.01)。两组间所有节段的患者间增强变异性无显著差异(P > 0.05)。
与 P1 相比,在薄患者中,P2 可获得更好的血管增强效果和可比的患者间增强变异性。